Company
CSPC Megalith Biopharmaceutical Co.,Ltd.
CSPC Megalith Biopharmaceutical Co.,Ltd. has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| SYS6010 | Phase 3 | Non-small Cell Lung Cancer |
Latest
No recent events.
Follow CSPC Megalith Biopharmaceutical Co.,Ltd. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.